A selection of recent
publications from the
Samsara team
Publications
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms (2021) Journal for Immunotherapy of Cancer
Digesting the crisis: autophagy and coronaviruses (2020) Microbial Cell
Importance of Quantifying Drug-Target Engagement in Cells (2020) ACS Med. Chem. Lett.
A discovery platform for the identification of caloric restriction mimetics with broad health-improving effects (2020) Autophagy
Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential (2019) Cell Metabolism
Biological Functions of Autophagy Genes: A Disease Perspective (2019)
Yeast as a tool to identify anti-aging compounds (2018) Oxford Journals: FEMS Yeast Research
The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species (2018) Nature Communications
Therapeutic modulation of autophagy: Which disease comes first? (2019) Cell Death & Differentiation
The Hallmarks of Aging (2013) Cell
The Lysoseeker™ Platform
A unique approach for discovering new autophagy therapeutics.
Neurodegeneration
What if we could tackle the cause of Alzheimer’s and Parkinson’s Disease?
Rare Monogenic Disease
What if we could offer real hope for serious rare genetic diseases?
Our Pipeline
Samsara is leveraging its knowledge of new autophagy biology.
Meet the Neuro Team – Modelling Neurodegeneration in a Dish
We caught up with Senior Scientists Gabriela Vilema Enríquez and Matthew Williamson on their work within the neuroscience team at Samsara.
CMT Research Foundation and Samsara Therapeutics Partner on a Novel Therapeutic Approach for CMT1A
CMT Research Foundation and Samsara Therapeutics Partner on a Novel Therapeutic Approach for CMT1A with the Potential to Reach Clinical Trials
Meet Nicole – From Books to Bench
Hear from Nicole Mak, a Biology student at Bath University, on her year in industry with Samsara.
Samsara Therapeutics Establishes Scientific Advisory Board
Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics
© 2021 Samsara Therapeutics | Legal Information | Privacy
© 2021 Samsara Therapeutics
Legal Information | Privacy